The SOMATREM FOR INJECTION is a the manufacturer industrial component. Key specifications include physical_form: FREEZE-DRIED POWDER, administration: INTRAMUSCULAR, features_provided: STERILE, primary_container_type: VIAL, primary_container_content_quantity: 5.000 MILLILITERS AFTER RECONSTITUTION, part_name_assigned_by_controlling_agency: SOMATROPIN FOR INJECTION VIAL 6S. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-285-5743, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| physical_form | FREEZE-DRIED POWDER |
| administration | INTRAMUSCULAR |
| features_provided | STERILE |
| primary_container_type | VIAL |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 5.000 MILLILITERS AFTER RECONSTITUTION |
| part_name_assigned_by_controlling_agency | SOMATROPIN FOR INJECTION VIAL 6S |
| NSN | 6505-01-285-5743 |
| SPECIAL FEATURES | VIAL CONTAINS 5 MG SOMATROPIN,25 MG MANNITOL,5 MG GLYCINE,AND 1.13 DIBASIC SODIUM PHOSPHATE; PH APPROXIMATELY 7.5 WHEN RECONSTITUTED; EACH VIAL IS SUPPLIED IN COMBINATION WITH 5 ML VIAL OF DILUTING SOLUTION OF WATER FOR INJECTION AS A UNIT; 6 UNITS PER PACKAGE |
| ADMINISTRATION | INTRAMUSCULAR |
| PHYSICAL FORM | FREEZE-DRIED POWDER |
| PRIMARY CONTAINER TYPE | VIAL |
| TOTAL PRIMARY CONTAINER QUANTITY | 6 |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLILITERS AFTER RECONSTITUTION |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SOMATROPIN FOR INJECTION VIAL 6S |